AJP - GI Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 284: G116-G122, 2003. First published September 11, 2002; doi:10.1152/ajpheart.00036.2002
0193-1857/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/1/G116    most recent
00036.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Medina, C.
Right arrow Articles by Malagelada, J.-R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Medina, C.
Right arrow Articles by Malagelada, J.-R.
Vol. 284, Issue 1, G116-G122, January 2003

Increased activity and expression of matrix metalloproteinase-9 in a rat model of distal colitis

Carlos Medina1, Sebastián Videla1, Anna Radomski1, Marek W. Radomski2, María Antolín1, Francisco Guarner1, Jaime Vilaseca1, Antonio Salas3, and Juan-R. Malagelada1

1 Digestive Disease Research Unit, Hospital Vall d'Hebron, 08035 Barcelona, Spain; 2 Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada T6G 2H7; 3 Department of Pathology, Hospital Mutua de Terrassa, 08221 Barcelona, Spain

Matrix metalloproteinases may play a role in tissue remodelling and destruction associated with inflammation. We investigated activity and expression of matrix metalloproteinases in a rat model of colitis and tested the therapeutic potential of a synthetic inhibitor (CGS-27023-A). Colitis was induced by dextran sulphate sodium (at 5% in drinking water for 5 days) in a group of eight rats, whereas a matched control group received plain water. Activity and expression of matrix metalloproteinases were measured in colonic tissue homogenates using zymography and Western blot on days 3 and 5 after induction of colitis. In another set of experiments, two groups of colitic rats (20 per group) were treated with CGS-27023-A (20 mg/kg) or vehicle, respectively. On days 5 and 14, colonic mucosal lesions were blindly scored by microscopic examination. Induction of colitis led to a significant upregulation of matrix metalloproteinase-9 protein and its activity, but no change in matrix metalloproteinase-2 activity was observed. Treatment with CGS-27023-A significantly decreased the extent and severity of epithelial injury but did not influence mucosal repair. We conclude that increased activity of matrix metalloproteinases may contribute to epithelial damage in this model of colitis.

gelatinases; inflammatory bowel disease; matrix metalloproteinase inhibitors; dextran sulphate sodium


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
C. Medina, A. Santana, M. C. Paz, F. Diaz-Gonzalez, E. Farre, A. Salas, M. W. Radomski, and E. Quintero
Matrix metalloproteinase-9 modulates intestinal injury in rats with transmural colitis
J. Leukoc. Biol., May 1, 2006; 79(5): 954 - 962.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online